What changed today in Aesthetics & Longevity: 3 trial updates, 3 new studies

The signal

NPHLA tracked 6 new official records on this desk today: 3 trial updates, 3 new studies.

Why this matters

New clearances, safety communications and research in aesthetic and regenerative medicine affect what practices offer, how they describe it and what patients are told.

NPHLA takeaway

These are factual summaries of official records with no interpretation. Open the primary documents for full details; NPHLA editors add analysis where developments warrant it.

Source file

[1]
New trial registered: Clinical Evaluation of Dual-Plane Technique PN-Based Treatment for Horizontal Neck Lines Using DNA Fragment Opmizing Technology Polynucleotide (DOT… (opens the source in a new tab)
Primary sourceClinicalTrials.gov (U.S. National Library of Medicine)Nov 2, 2026
[2]
Platelet-Rich Plasma and Platelet-Based Products in Facial Rejuvenation: State of the Evidence in Skin Quality, Periorbital Aesthetics, and Soft Tissue Augmentation (opens the source in a new tab)
Peer reviewedDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]Nov 2, 2026
[3]
New trial registered: Pilot Study of Combination Treatment With Subcision, Human Adipose Tissue-Derived Exosomes and Powdered Polydioxanone for Atrophic Acne Scars (opens the source in a new tab)
Primary sourceClinicalTrials.gov (U.S. National Library of Medicine)Nov 2, 2026
[4]
Combination Therapy of Injectables With Energy-Based Treatments for Facial Rejuvenation: An Updated Review (opens the source in a new tab)
Peer reviewedDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]Nov 2, 2026
[5]
New trial registered: Clinical Research on Deep-Plane Rejuran S Injection for Improvement in the Apperance of Periorbital Hollowing Using a Cannula Technique (opens the source in a new tab)
Primary sourceClinicalTrials.gov (U.S. National Library of Medicine)Nov 2, 2026
[6]
The FDA-Approved and Non-FDA-Approved Indications for Biostimulatory Fillers off the Face (opens the source in a new tab)
Peer reviewedDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]Nov 3, 2026
[7]
JAK Inhibitors in Alopecia Areata: Treatment Goals, Safety Data, and Long-Term Management (opens the source in a new tab)
News reportingDermatology TimesNov 3, 2026Industry coverage — headline and link only
[8]
Case 3: Alopecia Areata with Facial Involvement (opens the source in a new tab)
News reportingDermatology TimesNov 3, 2026Industry coverage — headline and link only

Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.

Update timeline

Nov 3, 2026, 2:05 PM ESTFirst published.
Nov 3, 2026, 6:35 PM ESTAdded 3 new official records.